Senior Director, Alliance & Program Management

GRANITE BIO is a private biotechnology company located in Basel (Switzerland).

GRANITE BIO is supported by top-tier investors with ~$100M raised to date. Based on fundamental research conducted over the last two decades, GRANITE BIO’s is pursuing a differentiated approach to transform inflammatory, autoimmune, and fibrotic conditions. Both our programs are first-in-class monoclonal antibodies for large market opportunities in Immunology and Inflammation. GRT-001, the lead asset, depletes inflammatory monocytes. It has just completed a Phase 1a trial in healthy volunteers and has shown favorable safety and pharmacodynamic effect.

The Phase 1b trial in patients with Ulcerative Colitis has just started. GRT-002 is an IL-3 neutralizing antibody that is thought to play an important role in type II inflammation.

Our company fosters an open, inter-disciplinary, diverse, international and creative working environment. We enable work-from-home options according to our internal workflows. The successful candidate will be highly motivated and enthusiastic with a positive “can do” attitude, attention to details and innovation, strong organizational and communication skills.

Reporting directly to the CEO, the Senior Director, Alliance & Program Management will lead the Alliance Management for our on-going collaboration with a large pharmaceutical company, Program Management for both our clinical-stage assets, and Quality functions. The role will partner closely with the executive team, clinical operations and finance to set operational priorities, optimize resource planning, and support the execution of the company’s long-term strategy.

• Serve as the primary operational and relationship lead for the company’s external development partner.
• Manage all collaboration governance, including Joint Steering Committee meetings, and potential working groups.
• Ensure fulfillment of all contractual obligations, milestones, deliverables, reporting requirements, and data-sharing timelines.
• Coordinate cross-functional inputs (clinical, CMC, regulatory, translational, finance, legal, IP) to prepare materials for governance meetings.
• Maintain strong, trust-based relationships with partner counterparts and ensure clear, consistent communication.
• Track joint progress against agreed plans, identify emerging risks or misalignments, and facilitate timely issue escalation and resolution.

• Lead integrated development planning and track execution across company programs.
• Facilitate cross-functional alignment and ensure issues or deviations are surfaced and resolved efficiently.
• Provide program updates and recommendation briefs to executive leadership and the Board.

• Provide leadership and general oversight of the QA function, communicating clear priorities and overseeing the implementation of quality activities that meet regulatory and company expectations.
• Review and monitor the QA function plans and progress, ensuring issues are addressed appropriately and escalated if needed, timelines are met, and the organization maintains effective quality processes and inspection readiness.
• Oversee GxP Quality Systems appropriate for clinical-stage operations, ensuring compliance with regulatory expectations

• Demonstrated alliance management experience in the biotech sector, ideally managing strategic development collaborations with large pharmaceutical partner.
• Strong clinical-stage drug development program management experience, including planning and execution of development programs in early to mid clinical stages.
• Demonstrated capability to lead cross‑functional teams and manage complex, multi‑party collaborations.
• Proven ability to operate both strategically and hands‑on in a fast‑paced, resource‑constrained environment.
• Proven ability to manage governance structures such as Joint Steering Committees and cross‑company working groups.
• Excellent communication, negotiation, and relationship‑building skills.
• Experience operating in clinical‑stage biotech environments with evolving processes and high strategic impact.

• Offices: Our well‑equipped laboratories…